Wealth Quarterback’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $245K | Buy |
1,322
+29
| +2% | +$5.38K | 0.12% | 123 |
|
|
2025
Q1 | $271K | Sell |
1,293
-229
| -15% | -$48K | 0.15% | 105 |
|
|
2024
Q4 | $270K | Sell |
1,522
-119
| -7% | -$21.1K | 0.13% | 98 |
|
|
2024
Q3 | $324K | Sell |
1,641
-401
| -20% | -$79.2K | 0.17% | 90 |
|
|
2024
Q2 | $350K | Sell |
2,042
-4,339
| -68% | -$744K | 0.2% | 81 |
|
|
2024
Q1 | $1.16M | Sell |
6,381
-1,899
| -23% | -$346K | 0.65% | 29 |
|
|
2023
Q4 | $1.28M | Buy |
8,280
+174
| +2% | +$27K | 0.78% | 21 |
|
|
2023
Q3 | $1.21M | Sell |
8,106
-502
| -6% | -$74.8K | 1.05% | 20 |
|
|
2023
Q2 | $1.16M | Buy |
8,608
+1,558
| +22% | +$210K | 0.8% | 22 |
|
|
2023
Q1 | $1.12M | Sell |
7,050
-170
| -2% | -$27.1K | 0.95% | 18 |
|
|
2022
Q4 | $1.17M | Buy |
7,220
+21
| +0.3% | +$3.39K | 0.97% | 20 |
|
|
2022
Q3 | $966K | Buy |
7,199
+2,851
| +66% | +$383K | 1.03% | 23 |
|
|
2022
Q2 | $666K | Buy |
+4,348
| New | +$666K | 0.52% | 42 |
|
|
2021
Q3 | $196K | Sell |
1,809
-327
| -15% | -$35.4K | 0.13% | 111 |
|
|
2021
Q2 | $241K | Buy |
+2,136
| New | +$241K | 0.15% | 102 |
|
|
2020
Q4 | $234K | Sell |
2,182
-504
| -19% | -$54K | 0.19% | 96 |
|
|
2020
Q3 | $264K | Hold |
2,686
| – | – | 0.24% | 91 |
|
|
2020
Q2 | $264K | Buy |
2,686
+245
| +10% | +$24.1K | 0.24% | 91 |
|
|
2020
Q1 | $186K | Sell |
2,441
-9,330
| -79% | -$711K | 0.17% | 110 |
|
|
2019
Q4 | $218K | Buy |
+11,771
| New | +$218K | 0.19% | 102 |
|